aminaftone has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutolo, M; Paolino, S; Pizzorni, C; Ruaro, B; Sulli, A | 1 |
| Antonioli, R; Beretta, L; Della Bella, S; Lenna, S; Salazar, G; Santaniello, A; Scorza, R; Toussoun, K | 1 |
1 trial(s) available for aminaftone and Scleroderma, Systemic
| Article | Year |
|---|---|
Effects of aminaftone 75 mg TID on soluble adhesion molecules: a 12-week, randomized, open-label pilot study in patients with systemic sclerosis.
Topics: 4-Aminobenzoic Acid; Cell Adhesion Molecules; E-Selectin; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; para-Aminobenzoates; Pilot Projects; Prospective Studies; Scleroderma, Systemic; Solubility; Vascular Cell Adhesion Molecule-1 | 2008 |
1 other study(ies) available for aminaftone and Scleroderma, Systemic
| Article | Year |
|---|---|
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.
Topics: Bosentan; Female; Fingers; Humans; Iloprost; Lasers; Methotrexate; Microcirculation; Microscopic Angioscopy; Middle Aged; para-Aminobenzoates; Raynaud Disease; Scattering, Radiation; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Tramadol; Treatment Outcome | 2017 |